The influence of uremic serum on interleukin-1β and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells

被引:5
作者
Higuchi, T [1 ]
Fukuda, N [1 ]
Yamamoto, C [1 ]
Yamazaki, T [1 ]
Oikawa, O [1 ]
Ohnishi, Y [1 ]
Okada, K [1 ]
Soma, M [1 ]
Matsumoto, K [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Med, Div Nephrol & Endocrinol,Itabashi Ku, Tokyo 1738610, Japan
关键词
chronic renal failure; cytokine; lipopolysaccharide; polymyxin-B; serum;
D O I
10.1111/j.1744-9987.2006.00346.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated whether or not uremic serum has an influence on IL-1 beta and IL-1Ra production by normal peripheral blood mononuclear cells (PBMC). Four groups of subjects were divided into healthy controls and non-dialyzed patients with chronic renal failure (CRF), patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) patients. We examined cytokine concentrations and cytokine production by PBMC from a normal subject at the density of 2.5 x 10(6) cells/mL incubated with 25% serum in the medium and serum containing polymyxin-B or lipopolysaccharides (LPS). IL-1Ra concentrations in the serum of the uremic groups were significantly higher than those of the controls. In IL-1 beta production by PBMC in medium with both serum and serum containing polymyxin-B, these values in the uremic groups were significantly higher than in the controls. In IL-1Ra production with serum containing polymyxin-B, these values in the uremic groups were significantly higher than in the controls. In contrast, in IL-1Ra production by PBMC in medium with serum containing LPS, these values in the uremic groups were significantly lower than in the controls. It was concluded that uremic serum not only contains nonendotoxemic cytokine-inducing substances, but also shows impaired cytokine production by PBMC in response to LPS.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 36 条
[21]  
NAKHLA LS, 1973, IMMUNOLOGY, V24, P229
[22]   ENDOTOXEMIA IN CHRONIC-RENAL-FAILURE [J].
NISBETH, U ;
HALLGREN, R ;
ERIKSSON, O ;
DANIELSON, BG .
NEPHRON, 1987, 45 (02) :93-97
[23]   MONOCYTE CELL-SURFACE CD14 EXPRESSION AND SOLUBLE CD14 ANTIGEN IN HEMODIALYSIS - EVIDENCE FOR CHRONIC EXPOSURE TO LPS [J].
NOCKHER, WA ;
SCHERBERICH, JE .
KIDNEY INTERNATIONAL, 1995, 48 (05) :1469-1476
[24]   PLASMA-LEVELS OF IL-1-BETA, TNF-ALPHA AND THEIR SPECIFIC INHIBITORS IN UNDIALYZED CHRONIC-RENAL-FAILURE, CAPD AND HEMODIALYSIS-PATIENTS [J].
PEREIRA, BJG ;
SHAPIRO, L ;
KING, AJ ;
FALAGAS, ME ;
STROM, JA ;
DINARELLO, CA .
KIDNEY INTERNATIONAL, 1994, 45 (03) :890-896
[25]   Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:: Mutations in Tlr4 gene [J].
Poltorak, A ;
He, XL ;
Smirnova, I ;
Liu, MY ;
Van Huffel, C ;
Du, X ;
Birdwell, D ;
Alejos, E ;
Silva, M ;
Galanos, C ;
Freudenberg, M ;
Ricciardi-Castagnoli, P ;
Layton, B ;
Beutler, B .
SCIENCE, 1998, 282 (5396) :2085-2088
[26]   LIPOPOLYSACCHARIDE ACTIVATION OF HUMAN ENDOTHELIAL AND EPITHELIAL-CELLS IS MEDIATED BY LIPOPOLYSACCHARIDE-BINDING PROTEIN AND SOLUBLE CD14 [J].
PUGIN, J ;
SCHURERMALY, CC ;
LETURCQ, D ;
MORIARTY, A ;
ULEVITCH, RJ ;
TOBIAS, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2744-2748
[27]   INFLUENZA SUBTYPE-SPECIFIC IMMUNOGLOBULIN-A AND IMMUNOGLOBULIN-G RESPONSES AFTER BOOSTER VERSUS ONE DOUBLE-DOSE VACCINATION IN HEMODIALYSIS-PATIENTS [J].
RAUTENBERG, P ;
PROPPE, D ;
SCHUTTE, A ;
ULLMANN, U .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (10) :897-900
[28]   IMPAIRED FUNCTION OF MACROPHAGE FC-GAMMA RECEPTORS IN END-STAGE RENAL-DISEASE [J].
RUIZ, P ;
GOMEZ, F ;
SCHREIBER, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (11) :717-722
[29]  
SECKINGER P, 1987, J IMMUNOL, V139, P1546
[30]  
TOBIAS PS, 1989, J BIOL CHEM, V264, P10867